Aethlon MedicalAEMD
Market Cap: $4.85M
About: Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Employees: 14
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
80% more funds holding
Funds holding: 10 [Q1] → 18 (+8) [Q2]
2% more capital invested
Capital invested by funds: $87.5K [Q1] → $89.2K (+$1.7K) [Q2]
0.02% less ownership
Funds ownership: 1.99% [Q1] → 1.96% (-0.02%) [Q2]
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
HC Wainwright & Co. Vernon Bernardino 40% 1-year accuracy 20 / 50 met price target | 1,913%upside $7 | Buy Maintained | 24 Jun 2024 |
Financial journalist opinion
Based on 5 articles about AEMD published over the past 30 days